Waystar (NASDAQ:WAY) Upgraded by Wall Street Zen to “Buy” Rating

Wall Street Zen upgraded shares of Waystar (NASDAQ:WAY) from a hold rating to a buy rating in a research report sent to investors on Saturday.

Several other research firms have also commented on WAY. Canaccord Genuity Group reduced their price target on Waystar from $54.00 to $30.00 and set a “buy” rating for the company in a research report on Wednesday, February 18th. Weiss Ratings raised Waystar from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, May 4th. The Goldman Sachs Group reduced their price target on Waystar from $44.00 to $38.00 and set a “buy” rating for the company in a research report on Wednesday, February 18th. BMO Capital Markets reduced their price target on Waystar from $47.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, February 18th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on Waystar from $42.00 to $37.00 and set a “buy” rating for the company in a research report on Thursday, March 12th. Three research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $36.14.

Waystar Trading Down 4.8%

Shares of NASDAQ WAY opened at $17.93 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.37. The business has a fifty day simple moving average of $23.51 and a two-hundred day simple moving average of $28.58. The firm has a market cap of $3.44 billion, a PE ratio of 26.76, a price-to-earnings-growth ratio of 0.71 and a beta of 0.21. Waystar has a twelve month low of $17.89 and a twelve month high of $41.49.

Waystar (NASDAQ:WAY) last issued its earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.03. The business had revenue of $313.87 million during the quarter, compared to analyst estimates of $311.74 million. Waystar had a return on equity of 6.99% and a net margin of 10.90%.Waystar’s revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Analysts expect that Waystar will post 1.45 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its stake in Waystar by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 12,330,872 shares of the company’s stock worth $403,836,000 after buying an additional 41,062 shares during the last quarter. Advent International L.P. purchased a new stake in Waystar during the 4th quarter valued at about $362,212,000. William Blair Investment Management LLC grew its stake in Waystar by 0.4% during the 4th quarter. William Blair Investment Management LLC now owns 5,282,220 shares of the company’s stock valued at $172,993,000 after purchasing an additional 19,033 shares during the last quarter. State Street Corp grew its stake in Waystar by 4.0% during the 4th quarter. State Street Corp now owns 4,134,052 shares of the company’s stock valued at $135,390,000 after purchasing an additional 159,183 shares during the last quarter. Finally, Alliancebernstein L.P. grew its stake in Waystar by 4.5% during the 3rd quarter. Alliancebernstein L.P. now owns 3,415,442 shares of the company’s stock valued at $129,514,000 after purchasing an additional 146,510 shares during the last quarter.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.